HY-100565-1mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
HY-100565-10mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
HY-100565-100mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
HY-100565-5mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
HY-100565-50mg
|
MedChemexpress LLC
|
SGC2085 [CAS 1821908-48-8]
|
|
Cancer-programmed cell death
|
|
HY-100669-10mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-100mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-2mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-25mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-5mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-100669-50mg
|
MedChemexpress LLC
|
Mycro 3 [CAS 944547-46-0]
|
|
Cancer-programmed cell death
|
|
HY-101125-10mg
|
MedChemexpress LLC
|
L-Moses [CAS 2079885-05-3]
|
|
Cancer-programmed cell death
|
|
HY-101125-5mg
|
MedChemexpress LLC
|
L-Moses [CAS 2079885-05-3]
|
|
Cancer-programmed cell death
|
|
HY-101535-5mg
|
MedChemexpress LLC
|
ARP101 [CAS 849773-63-3]
|
|
Cancer-Kinase/protease
|
|
HY-101597-10mg
|
MedChemexpress LLC
|
NVX-207 [CAS 745020-66-0]
|
|
Cancer-programmed cell death
|
|
HY-101597-100mg
|
MedChemexpress LLC
|
NVX-207 [CAS 745020-66-0]
|
|
Cancer-programmed cell death
|
|
HY-101597-25mg
|
MedChemexpress LLC
|
NVX-207 [CAS 745020-66-0]
|
|
Cancer-programmed cell death
|
|
HY-101597-5mg
|
MedChemexpress LLC
|
NVX-207 [CAS 745020-66-0]
|
|
Cancer-programmed cell death
|
|
HY-101597-50mg
|
MedChemexpress LLC
|
NVX-207 [CAS 745020-66-0]
|
|
Cancer-programmed cell death
|
|
HY-10299-10mg
|
MedChemexpress LLC
|
GSK-923295 [CAS 1088965-37-0]
|
|
Cancer-programmed cell death
|
|
HY-10299-100mg
|
MedChemexpress LLC
|
GSK-923295 [CAS 1088965-37-0]
|
|
Cancer-programmed cell death
|
|
HY-10299-5mg
|
MedChemexpress LLC
|
GSK-923295 [CAS 1088965-37-0]
|
|
Cancer-programmed cell death
|
|
HY-10299-50mg
|
MedChemexpress LLC
|
GSK-923295 [CAS 1088965-37-0]
|
|
Cancer-programmed cell death
|
|
HY-103713-10mg
|
MedChemexpress LLC
|
Seclidemstat [CAS 1423715-37-0]
|
|
Cancer-programmed cell death
|
|
HY-103713-100mg
|
MedChemexpress LLC
|
Seclidemstat [CAS 1423715-37-0]
|
|
Cancer-programmed cell death
|
|